Cargando…
β-Lactoglobulin-Modified Mesoporous Silica Nanoparticles: A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostate Cancer Cells
The clinical utilization of fenbendazole (FBZ) as a potential anticancer drug has been limited due to its low water solubility, which causes its low bioavailability. The development of a drug nanoformulation that includes the solubilizing agent as a drug carrier can improve solubility and bioavailab...
Autores principales: | Koohi Moftakhari Esfahani, Maedeh, Alavi, Seyed Ebrahim, Cabot, Peter J., Islam, Nazrul, Izake, Emad L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024783/ https://www.ncbi.nlm.nih.gov/pubmed/35456716 http://dx.doi.org/10.3390/pharmaceutics14040884 |
Ejemplares similares
-
PEGylated Mesoporous Silica Nanoparticles (MCM-41): A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostrate Cancer Cells
por: Esfahani, Maedeh Koohi Moftakhari, et al.
Publicado: (2021) -
Application of Mesoporous Silica Nanoparticles in Cancer Therapy and Delivery of Repurposed Anthelmintics for Cancer Therapy
por: Koohi Moftakhari Esfahani, Maedeh, et al.
Publicado: (2022) -
A PEGylated Nanostructured Lipid Carrier for Enhanced Oral Delivery of Antibiotics
por: Alavi, Seyed Ebrahim, et al.
Publicado: (2022) -
Modeling and prediction of cytotoxicity of artemisinin for treatment of the breast cancer by using artificial neural networks
por: Qaderi, Abdolhossein, et al.
Publicado: (2013) -
Organic Hollow Mesoporous Silica as a Promising Sandalwood Essential Oil Carrier
por: Xiao, Zuobing, et al.
Publicado: (2021)